heart failure

NEW ORLEANS (MedPage Today) -- Warfarin was statistically equal to aspirin in reducing death or stroke in heart failure patients, but increased GI bleeds, a randomized trial found.

February is American heart awareness month, highlighting efforts by doctors to promote prevention, early diagnosis and better treatment.

Heart attack and stroke might be the most familiar cardiovascular problems, but heart failure is another chronic and potentially fatal disease.

(MedPage Today) -- The FDA has approved the EXCOR pediatric cardiac assist device for children with heart failure awaiting a transplantation.

(MedPage Today) -- Regions that have a wealth of cardiologists have more congestive heart failure patients hospitalized for treatment, and more of those patients are rehospitalized after discharge, according to a Commonwealth Fund analysis of Medicare records.

(MedPage Today) -- Heart failure patients' sexual health improved with their physical health after implantation of a left ventricular assist device, results of a small study showed.

(MedPage Today) -- Valve replacement improves outcomes for infective endocarditis complicated by heart failure, a prospective observational study determined.

(MedPage Today) -- For patients with type 2 diabetes, tight glycemic control does not reduce the risk of heart failure, according to a large meta-analysis.

It could be the first real treatment for heart failure: a patient's own heart stem cells, harvested during bypass surgery.

The first 16 patients treated have better heart function and repair of heart-attack damage.

CHICAGO (AP) -- Hospital stays for heart failure fell a remarkable 30 percent in Medicare patients over a decade, the first such decline in the United States and forceful evidence that the nation is making headway in reducing the billion-dollar burden of a common condition....

(University of North Carolina School of Medicine) A collaborative network of European and North American scientists, including from the University of North Carolina at Chapel Hill School of Medicine, have been awarded a total of $6 million over five years to explore the biology of heart failure and to find new therapies for it.